Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1661 Views
-
Last post by goellerc
-
- 0 Replies
- 1121 Views
-
Last post by ElliotB
-
- 61 Replies
- 13386 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4869 Views
-
Last post by NHE
-
- 5 Replies
- 13294 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1504 Views
-
Last post by ElliotB
-
- 0 Replies
- 741 Views
-
Last post by DIM
-
- 0 Replies
- 467 Views
-
Last post by NHE
-
- 0 Replies
- 1430 Views
-
Last post by NHE